echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > CHMP recommends Saphnelo for systemic lupus erythematosus

    CHMP recommends Saphnelo for systemic lupus erythematosus

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Systemic lupus erythematosus (SLE) is a complex of self- immune disease that can affect any organ of the body


    Immune quality of life

    Saphnelo (anifrolumab) is a first-class type 1 interferon receptor antibody, which has been recommended for marketing in the European Union


    SLE, the most common type of lupus, is an autoimmune disease in which the immune system attacks one's own tissues, causing extensive inflammation and tissue damage in the affected organs


    AstraZeneca’s Saphnelo has been shown to be effective in reducing the overall disease activity of patients with systemic lupus erythematosus


    AstraZeneca’s Saphnelo has been shown to be effective in reducing the overall disease activity of patients with systemic lupus erythematosus


    Compared with placebo, in these trials, more patients treated with Saphnelo had reduced overall disease activity in the entire organ system and continued to reduce oral corticosteroid (OCS) use


    Ian Bruce, Professor of Rheumatology at the University of Manchester and Chairman of the Steering Committee of the Saphnelo SLE Clinical Development Project, said: “Systemic lupus erythematosus is a complex and heterogeneous disease that can adversely affect the quality of life of people


     

    Original source:

    Original source:

    https:// href="https://" target="_blank" rel="noopener">https:// https://


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.